Allstate (NYSE:ALL) Price Target Raised to $225.00 at UBS Group

Allstate (NYSE:ALL) had its price target boosted by UBS Group from $216.00 to $225.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has a buy rating on the insurance provider’s stock.

A number of other research analysts have also weighed in on ALL. Wells Fargo & Company reduced their price objective on shares of Allstate from $177.00 to $175.00 and set an “equal weight” rating for the company in a research note on Friday, August 16th. Morgan Stanley boosted their price target on shares of Allstate from $202.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Bank of America boosted their price objective on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research report on Friday, October 18th. StockNews.com cut shares of Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. Finally, Barclays boosted their price target on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Allstate has an average rating of “Moderate Buy” and an average price target of $210.31.

Allstate Price Performance

ALL stock opened at $190.55 on Monday. The stock has a market capitalization of $50.46 billion, a PE ratio of 12.34, a price-to-earnings-growth ratio of 1.71 and a beta of 0.48. The company’s 50-day moving average is $188.89 and its 200-day moving average is $175.59. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. Allstate has a 1 year low of $127.93 and a 1 year high of $198.79.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same quarter last year, the firm earned $0.81 EPS. The firm’s revenue for the quarter was up 14.7% compared to the same quarter last year. Equities research analysts expect that Allstate will post 15.23 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Thomas J. Wilson sold 90,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the transaction, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now owns 19,163 shares in the company, valued at $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 192,530 shares of company stock worth $34,967,665. Insiders own 1.80% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of ALL. Northwest Investment Counselors LLC acquired a new stake in Allstate during the 3rd quarter worth approximately $28,000. Catalyst Capital Advisors LLC acquired a new stake in Allstate during the 3rd quarter worth approximately $29,000. Versant Capital Management Inc increased its position in Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 78 shares in the last quarter. Family Firm Inc. acquired a new stake in Allstate during the 2nd quarter worth approximately $38,000. Finally, MCF Advisors LLC increased its position in Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.